Inventor · disambiguated record
Hao Li
Also filed as: LI HAO · LI HAO-KANG · SHU XIAO ZHENG
46 granted patents·27 pending applications·512 citations·filing 2002–2024
98Inventor score
Files withSYNTA PHARMACEUTICALS CORP20UNIV MICHIGAN REGENTS8JIANGSU HENGRUI MEDICINE CO6ACEPODIA BIOTECHNOLOGIES LTD4ALBERT EINSTEIN COLLEGE MEDICINE3
Top patents by PatentIndex Score
73 records- 0197US8053456B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2007·Granted Nov 8, 2011·58 cites·12 claims
- 0296US8415377B2Triazole compounds that modulate HSP90 activitySUN LIJUN·Filed 2011·Granted Apr 9, 2013·40 cites·19 claims
- 0396US8318790B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2007·Granted Nov 27, 2012·49 cites·68 claims
- 0496US7615552B2Fused heterocyclic compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Nov 10, 2009·87 cites·46 claims
- 0595US11147885B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2020·Granted Oct 19, 2021·5 cites·20 claims
- 0695US8835464B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Sep 16, 2014·32 cites·17 claims
- 0794US10632209B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Apr 28, 2020·9 cites·18 claims
- 0894US8742133B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2008·Granted Jun 3, 2014·36 cites·15 claims
- 0994US7709518B2Compounds for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted May 4, 2010·33 cites·19 claims
- 1093US7919487B2Heteroaryl compoundsSYNTA PHARMACEUTICALS CORP·Filed 2005·Granted Apr 5, 2011·34 cites·15 claims
- 1189US11833210B2ASH1L inhibitors and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Dec 5, 2023·1 cites·19 claims
- 1289US11786602B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2021·Granted Oct 17, 2023·1 cites·20 claims
- 1388US10555942B2Emetine compounds for treatment and prevention of flavivirus infectionUNIV FLORIDA STATE RES FOUND·Filed 2018·Granted Feb 11, 2020·7 cites·15 claims
- 1488US9206162B2Triazole compounds that modulate Hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2015·Granted Dec 8, 2015·6 cites·3 claims
- 1588US8927548B2Triazole compounds that modulate HSP90 activityYING WEIWEN·Filed 2012·Granted Jan 6, 2015·10 cites·9 claims
- 1687US11110177B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2018·Granted Sep 7, 2021·2 cites·16 claims
- 1787US9006277B2Triazole compounds that modulate HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Apr 14, 2015·7 cites·8 claims
- 1886US9120745B2Triazole compounds that modualte HSP90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Granted Sep 1, 2015·7 cites·24 claims
- 1985US12285490B2ASH1L degraders and methods of treatment therewithUNIV MICHIGAN REGENTS·Filed 2023·Granted Apr 29, 2025·0 cites·19 claims
- 2085US8324184B2Anti-adhesion composites and methods of use thereofPRESTWICH GLENN D·Filed 2004·Granted Dec 4, 2012·27 cites·40 claims
- 2185US7338951B2Pyridine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2004·Granted Mar 4, 2008·18 cites·44 claims
- 2284US9120799B2Crystalline bipyridinium radical complexes and uses thereofUNIV NORTHWESTERN·Filed 2012·Granted Sep 1, 2015·4 cites·21 claims
- 2382US10857190B2Microbial hyperswarmers and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2016·Granted Dec 8, 2020·2 cites·11 claims
- 2481US10988472B2Compounds and method for blocking transmission of malarial parasiteUS HEALTH·Filed 2017·Granted Apr 27, 2021·3 cites·8 claims
- 2581US8269017B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2010·Granted Sep 18, 2012·4 cites·20 claims
- 2680US6861436B21-glyoxylamide indolizines for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Mar 1, 2005·11 cites·42 claims
- 2778US8524756B2Compounds for inflammation and immune-related usesSYNTA PHARMACEUTICALS CORP·Filed 2012·Granted Sep 3, 2013·3 cites·25 claims
- 2878US8318730B2Fused hetrocyclic compoundsONO MITSUNORI·Filed 2009·Granted Nov 27, 2012·3 cites·2 claims
- 2978US7884094B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2006·Granted Feb 8, 2011·2 cites·8 claims
- 3077US11273205B2IL-15 protein complex pharmaceutical compositionJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Mar 15, 2022·1 cites·14 claims
- 3177US7687498B2Pyridine compoundsSYNTA PHARMACEUTICALS CORP·Filed 2008·Granted Mar 30, 2010·2 cites·21 claims
- 3274US12090180B2Microbial hyperswarmers and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2021·Granted Sep 17, 2024·0 cites·5 claims
- 3374US6958348B23-glyoxylamideindoles for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2002·Granted Oct 25, 2005·5 cites·16 claims
- 3473US8173651B2Pyridine compoundsONO MITSUNORI·Filed 2010·Granted May 8, 2012·2 cites·11 claims
- 3572US11207315B2Emetine compounds for treatment and prevention of flavivirus infectionUNIV FLORIDA STATE RES FOUND·Filed 2019·Granted Dec 28, 2021·0 cites·19 claims
- 3668US8314134B2Compounds for inflammation and immune-related usesCHEN SHOUJUN·Filed 2010·Granted Nov 20, 2012·1 cites·25 claims
- 3767US12163174B1Method for producing sclareol by fermentation of cigar tobacco flower budsTOBACCO RES INSTITUTE OF HUBEI PROVINCE·Filed 2024·Granted Dec 10, 2024·0 cites·6 claims
- 3866US2024074967A1Method for the treatment of an auditory disease or conditionRINRI THERAPEUTICS LTD·Filed 2023·Application pending·0 cites
- 3964US11141441B2Microbial hyperswarmers and uses thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2020·Granted Oct 12, 2021·0 cites·2 claims
- 4064US2024245645A1Ash1l inhibitors and methods and treatment therewithUNIV MICHIGAN REGENTS·Filed 2024·Application pending·0 cites
- 4161US11753408B2Compounds and method for blocking transmission of malarial parasiteUS HEALTH·Filed 2021·Granted Sep 12, 2023·0 cites·8 claims
- 4261US2024336933A1Rice dominant male sterile gene sms and application thereofRICE RES INSTITUTE ANHUI ACADEMY OF AGRICULTURAL SCIENCES·Filed 2024·Application pending·0 cites
- 4360US9090603B2Compounds for the treatment of proliferative disordersSYNTA PHARMACEUTICALS CORP·Filed 2013·Granted Jul 28, 2015·0 cites·14 claims
- 4459US8598366B2Compounds for the treatment of proliferative disordersSUN LIJUN·Filed 2012·Granted Dec 3, 2013·0 cites·10 claims
- 4559US2015183771A1Triazole compounds that modulate hsp90 activitySYNTA PHARMACEUTICALS CORP·Filed 2014·Application pending·0 cites
- 4658US10112960B2Methods for producing borylated arenesDOW AGROSCIENCES LLC·Filed 2014·Granted Oct 30, 2018·0 cites·13 claims
- 4758US2025002555A1Methods for therapy and rehabilitation of movement disordersUNIV CITY HONG KONG·Filed 2023·Application pending·0 cites
- 4857US2019062350A1Methods for producing borylated arenesDOW AGROSCIENCES LLC·Filed 2018·Application pending·0 cites
- 4956US2025041340A1A novel method of treating targeted abnormal cells, and cytotoxic cell used thereinACEPODIA BIOTECHNOLOGIES LTD·Filed 2022·Application pending·0 cites
- 5054US2006004044A13-glyoxylamideindoles for treating cancerSYNTA PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hao Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →